Astellas Unveils New Life Sciences Center in Cambridge, Massachusetts to Accelerate the Discovery of Breakthrough Therapies

The new LEED-certified construction is home to the company's first U.S.-based SakuLab™, a shared laboratory space for highly innovative external partners. The new ALSC will also house the company's Engineered Small Molecules (ESM) unit which focuses on advancing research into targeted protein degradation, a novel treatment approach aimed at removing specific proteins from cells to unlock targets that have previously been considered 'undruggable.' Approximately 400 Astellas employees will operate out of the ...